Literature DB >> 19918313

The role of hepatic cytochrome P-450 in sepsis.

Asha Jacob1, Mian Zhou, Rongqian Wu, Ping Wang.   

Abstract

Severe sepsis is a common, expensive, and fatal condition with as many deaths annually as those from acute myocardial infarctions. The average cost per case seems to exceed $22,000. The increased morbidity and mortality attributed to sepsis could be due to the lack of our understanding of mediators and factors responsible for early cellular alterations and thus could not be intervened which result in progressive deterioration of cell and organ function and even death. It has been well documented that hepatocellular dysfunction occurs early in sepsis and it contributes to multiple organ failure and ultimately death; however the exact mechanism is poorly understood. We and others have shown that cytochrome P-450 (CYP) enzyme system, a superfamily of heme proteins responsible for the metabolism of a variety of endogenous and exogenous substances, plays a crucial role in the prevention of hepatocellular dysfunction in sepsis. In this review, we describe the alterations of CYP enzymes in the experimental model of sepsis and provide the limited information available in septic and severely injured patients. We also review the potential mechanism for the alterations of CYP enzymes in sepsis. Finally, we highlight the importance of future studies needed to understand the regulation of CYP isoforms to develop therapy for hepatocellular dysfunction in sepsis.

Entities:  

Keywords:  CYP enzymes; Cytochrome P-450; hepatic dysfunction; liver; sepsis

Year:  2009        PMID: 19918313      PMCID: PMC2770183     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  99 in total

1.  Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis.

Authors:  D J Koo; I H Chaudry; P Wang
Journal:  J Surg Res       Date:  1999-05-15       Impact factor: 2.192

2.  Impairment of the ryanodine-sensitive calcium release channels in the cardiac sarcoplasmic reticulum and its underlying mechanism during the hypodynamic phase of sepsis.

Authors:  L W Dong; L L Wu; Y Ji; M S Liu
Journal:  Shock       Date:  2001-07       Impact factor: 3.454

Review 3.  Structure of cytochrome p450s and personalized drug.

Authors:  Jing-Fang Wang; Cheng-Cheng Zhang; Kuo-Chen Chou; Dong-Qing Wei
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

4.  Kupffer cell-mediated differential down-regulation of cytochrome P450 metabolism in rat hepatocytes.

Authors:  N Milosevic; H Schawalder; P Maier
Journal:  Eur J Pharmacol       Date:  1999-02-26       Impact factor: 4.432

5.  Suppression of hepatocyte CYP1A2 expression by Kupffer cells via AhR pathway: the central role of proinflammatory cytokines.

Authors:  Rongqian Wu; Xiaoxuan Cui; Weifeng Dong; Mian Zhou; H Hank Simms; Ping Wang
Journal:  Int J Mol Med       Date:  2006-08       Impact factor: 4.101

6.  Suppression of hepatic cytochrome p450-mediated drug metabolism during the late stage of sepsis in rats.

Authors:  Sang-Ho Lee; Sun-Mee Lee
Journal:  Shock       Date:  2005-02       Impact factor: 3.454

7.  Differential alterations in microvascular perfusion in various organs during early and late sepsis.

Authors:  P Wang; M Zhou; M W Rana; Z F Ba; I H Chaudry
Journal:  Am J Physiol       Date:  1992-07

8.  Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene induction by the aryl hydrocarbon receptor and hypoxia-inducible factor 1alpha.

Authors:  S Tomita; C J Sinal; S H Yim; F J Gonzalez
Journal:  Mol Endocrinol       Date:  2000-10

9.  Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture.

Authors:  J Muntané-Relat; J C Ourlin; J Domergue; P Maurel
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

Review 10.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

View more
  17 in total

1.  Prolonged benzodiazepine coma as a complication of morbid obesity.

Authors:  Pascal Augustin; Mathieu Desmard; Konstantinos Arapis; Pierre Fournier; Lara Ribeiro-Parenti; Philippe Montravers
Journal:  Obes Surg       Date:  2013-09       Impact factor: 4.129

2.  In the search for reliable biomarkers for the early diagnosis of autism spectrum disorder: the role of vitamin D.

Authors:  Afaf El-Ansary; John J Cannell; Geir Bjørklund; Ramesa Shafi Bhat; Abeer M Al Dbass; Hanan A Alfawaz; Salvatore Chirumbolo; Laila Al-Ayadhi
Journal:  Metab Brain Dis       Date:  2018-03-01       Impact factor: 3.584

3.  Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.

Authors:  Joel Salazar-Flores; Luis A Torres-Reyes; Gabriela Martínez-Cortés; Rodrigo Rubi-Castellanos; Martha Sosa-Macías; José F Muñoz-Valle; César González-González; Angélica Ramírez; Raquel Román; José L Méndez; Andrés Barrera; Alfredo Torres; Rafael Medina; Héctor Rangel-Villalobos
Journal:  Genet Test Mol Biomarkers       Date:  2012-08-22

4.  Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline.

Authors:  Wanda C Reygaert
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

5.  Administration of a CXCL12 Analog in Endotoxemia Is Associated with Anti-Inflammatory, Anti-Oxidative and Cytoprotective Effects In Vivo.

Authors:  Semjon Seemann; Amelie Lupp
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

6.  Comprehensive comparison of three different animal models for systemic inflammation.

Authors:  Semjon Seemann; Franziska Zohles; Amelie Lupp
Journal:  J Biomed Sci       Date:  2017-08-24       Impact factor: 8.410

7.  Protective Effect of Casperome®, an Orally Bioavailable Frankincense Extract, on Lipopolysaccharide- Induced Systemic Inflammation in Mice.

Authors:  Konstantin Loeser; Semjon Seemann; Stefanie König; Isabell Lenhardt; Mona Abdel-Tawab; Andreas Koeberle; Oliver Werz; Amelie Lupp
Journal:  Front Pharmacol       Date:  2018-04-20       Impact factor: 5.810

Review 8.  Clinical review: The liver in sepsis.

Authors:  Nicolas Nesseler; Yoann Launey; Caroline Aninat; Fabrice Morel; Yannick Mallédant; Philippe Seguin
Journal:  Crit Care       Date:  2012-10-30       Impact factor: 9.097

9.  Advances in sepsis-associated liver dysfunction.

Authors:  Dawei Wang; Yimei Yin; Yongming Yao
Journal:  Burns Trauma       Date:  2014-07-28

10.  Administration of AMD3100 in endotoxemia is associated with pro-inflammatory, pro-oxidative, and pro-apoptotic effects in vivo.

Authors:  Semjon Seemann; Amelie Lupp
Journal:  J Biomed Sci       Date:  2016-10-03       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.